Finally, additional studies are needed to investigate whether circadian REMS changes are accompanied by age-related cognitive decline and brain markers usually explored in the context of neurodegenerative diseases (e.g., amyloid-β and tau deposition). Here, MAPT is linked to neurodegenerative disease.